The RBI delivered no surprises this week. If a hike does materialise in the next few months, a shock from food prices would be the most likely trigger. Meanwhile, although the Serum Institute is likely to reverse its vaccine production cuts soon, the move highlights the slow pace at which vaccination is expanding in India, leaving the population still vulnerable to further outbreaks.
Become a client to read more
This is premium content that requires an active Capital Economics subscription to view.
Already have an account?
You may already have access to this premium content as part of a paid subscription.
Sign in to read the content in full or get details of how you can access it
Register for free
Sign up for a free account to:
- Unlock additional content
- Register for Capital Economics events
- Receive email updates and economist-curated newsletters
- Request a free trial of our services